-
China's new coronavirus vaccine research and development has made these new progress
Time of Update: 2022-10-20
The reporter recently learned from the scientific research team of the joint prevention and control mechanism of the State Council and related scientific research teams that China adheres to multiple technical routes in parallel, and new progress has been made in the research and development of new coronavirus vaccines.
-
COVID-19 vaccine breakthrough and booster｜Science Weekly Selection
Time of Update: 2022-01-10
In this regard, Gupta and Topol reviewed recent studies on the breakthrough infection of the COVID-19 vaccine and the efficacy of boosters in preventing SARS-CoV-2 variants (such as Delta) .
Click "Read the original text" below to visit the English original text of this issue of Science.
-
UK data suggests that vulnerable children between 5 and 11 years old should be provided with COVID-19 vaccine
Time of Update: 2022-01-08
The British government vaccine consultant said that low-dose COVID-19 vaccine should be provided to disadvantaged primary school students .
COVID-19A low-dose COVID-19 vaccine has recently been approved for use in the UK and is expected to be used in vulnerable children , but the government has not yet decided to vaccinate all children aged 5 to 11 .
-
N Engl J Med: How effective is the third shot of BNT162b2 vaccine in neutralizing Omicron
Time of Update: 2022-01-08
In the samples obtained from participants who had received two vaccinations, it was observed that the neutralization efficiency of the BNT162b2 vaccine against all the tested variants of interest (β, δ, and omicron) was significantly lower than that of the wild-type virus.
-
Cansino new crown vaccine: 2 doses of inactivated and 1 dose of inhalation, the level of neutralizing antibodies increased by up to 300 times
Time of Update: 2021-11-05
The speech was divided into four chapters, including the overall overview of global new crown vaccine research and development, the research and development results and clinical research progress of Cansino adenovirus vector new crown vaccine, the interpretation of clinical data of Keweisha® booster immunization, and the immunization of Keweisha® inhaled dosage form Mechanism and advantages .
-
ANRPC: Global natural rubber production is expected to drop by 12.4% in February, while consumption will increase by 47.5
Time of Update: 2021-10-27
Since most natural rubber producing countries have favorable market fundamentals during the seasonal overwintering period, it supports the upward trend of monthly average prices in major physical markets in the base month .
-
Zhong Nanshan: Over 80% of China's population can be herd immunity after being vaccinated
Time of Update: 2021-09-03
academician Zhong Nanshan said that research on the previous Guangzhou epidemic showed that the overall protection rate of the domestic inactivated vaccine against the Delta strain was close to 60%, and the critical illness protection rate was 100% .
-
US Centers for Disease Control report: Pfizer, Modena vaccines may be related to young people suffering from myocarditis
Time of Update: 2021-08-08
A consultant doctor from the Centers for Disease Control and Prevention (CDC) issued a report on Wednesday (23rd) that Pfizer's new crown vaccine and Modena's new crown vaccine may be related to rare cases of heart inflammation in young people .
-
More than 30 mutations of the new coronavirus have appeared in people with AIDS, and the emergency use of the new coronavirus vaccine has been extended to over 3 years of age. The progress of new
Time of Update: 2021-06-28
Research finds that new crown vaccine recipients have lower levels of antibodies against Indian variantsResearch finds that new crown vaccine recipients have lower levels of antibodies against Indian variantsSource: the LancetSource: the Lancet Source: the LancetIn a work published in The Lancet on June 3, the latest laboratory data showed that the blood of the vaccinators can identify and fight against the new SARS-CoV-2 delta variant discovered in India for the first time (B.
-
NEJM: Evaluation of the effectiveness of BNT162b2 mRNA vaccine after mass vaccination in Israel
Time of Update: 2021-03-20
Infections 14-20 days after the first vaccination, and at least 7 days after the second vaccination, the endpoint event data for the vaccinated vs.
14-20 days after the first vaccination, and at least 7 days after the second vaccination, the endpoint event data for the vaccinated vs.
-
The U.S. will advance Phase III clinical trials of three new crown-candidate vaccines
Time of Update: 2021-03-02
Robert Scully, director of the Department of Infectious Diseases at the University of California, San Diego, told Xinhua that it is relatively easy for candidate vaccines to enter Phase I clinical trials and that conditions such as enabling the immune system to recognize viruses need to be met.
-
The European Union has approved a new crown vaccine for conditional listing
Time of Update: 2021-01-02
Pharma.com December 22 - The European Medicines Agency on the 21st of the United States Pfizer Pharmaceutical Co., Ltd. and The German bio-new technology company jointly developed a new crown vaccine safety and effectiveness of a positive assessment, the European Commission subsequently approved the vaccine in the European Union conditional listing.
-
The CEOs of nine science-based new crown vaccine development companies have signed a public commitment
Time of Update: 2020-09-20
in line with guidelines from expert regulators such as the FDA on the development of new crown vaccines, in line with existing standards and norms, with a view to the public health interest, we are committed to " always keeping the safety and well-being of vaccinated people a top priority." adhere to high scientific and ethical standards in the conduct of clinical trials and the strictness of production processes.
-
Nature Communication: Cancer vaccine can improve the effectiveness of immunotherapy
Time of Update: 2020-05-29
A powerful vaccine could be created to improve the effectiveness of immuno therapy by increasing mutation rates in cancer cells, a new study suggests Scientists used a molecule called APOBEC3B ,
-
Science Sub-journal: The therapeutic effect of malaria vaccine can be predicted based on molecular markers
Time of Update: 2020-05-14
2020 May 15 News / BioValley BIOON / --- according to a study ISGlobal, the front and rear of immune markers can predict the protective effect of the vaccine induced This study analyzed the malaria
